Safety of Tofacitinib in the COVID-19 Pandemic-Enough Is Not Enough.

Safety of Tofacitinib in the COVID-19 Pandemic-Enough Is Not Enough. Inflamm Bowel Dis. 2021 07 27; 27(8):e89.

View in: PubMed